retatrutide safety retatrutide clinical trial Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 New GLP-3 drug significantly slashes

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, which often causes temporary nausea, constipation, or reduced appetiteespecially in the first month

The medications arent designed for people who just want to lose a few pounds

Unlike oral medications, Retatrutide is not swallowed but self-injected weekly

Clinically, retatrutide can aid in reducing skin laxity post-weight loss and provide metabolic benefits such as fat reduction and enhanced insulin sensitivity

This article will explore why GLP-1 medications can lead to dehydration, the specific minerals your body loses, and why replenishing your electrolytes is a non-negotiable part of your daily routine

Among the frontrunners are Semaglutide and Tirzepatide, both widely recognized for their proven efficacy